Invokana (canagliflozin) / Mundipharma, Mitsubishi Tanabe, J&J, Daiichi Sankyo  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Invokana (canagliflozin) / J&J, Daiichi Sankyo, Mitsubishi Tanabe
HARRP, NCT06099067: Harmonizing RCT-Duplicate Emulations In A Real World Replication Program

Completed
N/A
239990
Europe
Canagliflozin, DPP4 inhibitor, Liraglutide, Saxagliptin, 2nd generation Sulfonylurea
AstraZeneca
Type 2 Diabetes Mellitus
08/23
08/23

Download Options